Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Cytidine → 4-amino-1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Cytidine | HCID 6175 | — |
| 반응물 | Potassium Hydroxide | HCID 14797 | — |
| 용매 | Methanol | HCID 887 | — |
| 생성물 | 4-amino-1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | HCID 1265901 | — |
반응 단계
The process of claim 27 wherein 1-(β-D-ribofuranosyl)-4-aminopyrimidin-2-one is contacted with potassium hydroxide in methanol to form 1-(α-D-ribofuranosyl)-4-aminopyrimidin-2-one
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05420266 |
| 출처 데이터셋 | uspto-grants-1995_05 |
| ORD ID | ord-12b6769bb04b422a8e38d1043b6f9c35 |
| 출처 메모 | uspto-grants-1995_05 |